BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Where will you be launching your new orphan medicine? You may 
 be confident that your Global market access strategy will support access 
 in key launch markets like the UK\, the EU4 and the US\, but have you tho
 ught about other markets? Have you looked at the reimbursement requiremen
 ts for rare disease products in the Nordic markets? Have you explored opp
 ortunities in growth markets\, such as those in the Middle East and North
  Africa (MENA) region?\n\nThis Rare Disease Day\, our Global Market Acces
 s team will compare and contrast access opportunities and challenges for 
 rare disease treatments in the differing markets of the Nordic and MENA r
 egions\, asking: what does this mean for your overarching market access s
 trategy?\n\nJoin us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thu
 rsday 29th February\, to explore rare disease market access challenges an
 d learn more about these high potential markets: register here.\n\nIn an 
 earlier rare disease market access webinar\, we explored the&nbsp\;challe
 nges facing orphan medicines entering key European markets. Here\, we wil
 l explore some of the markets that can be neglected or forgotten about by
  Global teams. The rare markets if you like.\n\nOur Global Market Access 
 experts will explore contrasting regions to showcase the significant diff
 erences between international markets when it comes to:\n\n\nOverall and 
 rare disease patient populations\nAccess inequalities\nTime to diagnosis\
 nAccess to innovation timelines\nHealthcare funding\nHealth technology as
 sessment frameworks\n\nRobert Taaffe&nbsp\;(Consultant – Global Market Ac
 cess) will present his research into the market access conditions in the 
 MENA regions\, with a focus on the rare disease reimbursement landscape i
 n growth markets in Egypt\, Saudi Arabia\, and the United Arab Emirates.\
 n\nMichelle James&nbsp\;(Associate Consultant – Global Market Access) wil
 l showcase market access and reimbursement routes in the more established
 \, yet smaller populations in the Nordic regions. Michelle will focus on 
 access in Denmark\, Sweden\, and Norway.\n\nAfter this initial comparison
 \,&nbsp\;Clare Foy&nbsp\;(Director – Global Market Access) will lead a di
 scussion on the opportunities and challenges of launching in markets with
  different conditions and requirements\, and how this should play into yo
 ur overarching Global market access strategy.\n\nLearn more at: https://m
 techaccess.co.uk/rare-disease-market-access-nordic-and-mena/\n\nIf you ca
 nnot attend the webinar but would like to know more\, please&nbsp\;regist
 er&nbsp\;nonetheless\, as all registrants will receive a recording of the
  webinar.\n\nThe webinar is free and open to all Market Access\, HEOR\, S
 trategic\, and Commercial teams in Pharmaceutical companies. Some colleag
 ues from other organisations may attend at the discretion of Mtech Access
 .\n
DTEND:20240229T140000
DTSTAMP:20260514T155810Z
DTSTART:20240229T130000
LOCATION:\,
SEQUENCE:0
SUMMARY:Where will you be launching your new orphan medicine? You may be c
 onfident that your Global market access strategy will support access in k
 ey launc...
UID:cd89e181-aa42-4c0c-b0c9-4dfe57d39483
END:VEVENT
END:VCALENDAR